te Sun Pharma: Today Latest News, Photos, Videos about Sun Pharma - Zee Business

हिंदी में पढ़ें

Sun Pharma

Sun Pharma to fully acquire subsidiary Taro Pharma for Rs 2,892 crore; shares rise

Sun Pharma to fully acquire subsidiary Taro Pharma for Rs 2,892 crore; shares rise

Thu, Jan 18, 2024

On Thursday, Sun Pharma shares ended weaker by Rs 14.3, or 1.1 per cent, at Rs 1,299.3 apiece.

Sun Pharma inks pact with Bayer to sell drug for chronic kidney disease

Sun Pharma inks pact with Bayer to sell drug for chronic kidney disease

Wed, Jan 17, 2024

Under the terms of the agreement, Bayer has granted non-exclusive rights to Sun Pharma to market and distribute a second Finerenone product under the brand name Lyvelsa. Finerenone was first launched by Bayer under the brand name Kerendia in 2022.

Sun Pharma Shares Hit 52-Week High Post Acquiring Israel's Libra Merger Ltd | Stock Market News

Sun Pharma Shares Hit 52-Week High Post Acquiring Israel's Libra Merger Ltd | Stock Market News

Wed, Jan 03, 2024

Sun Pharma hits a new high after acquiring Israel's Libra Merger, consolidating its presence in the region. This follows a recent US investment in Lyndra Therapeutics. We break down the deals and their potential impact on Sun Pharma's future.

TRENDING NOW

Sun Pharma top Sensex gainer; share price spikes 7% post Q4 FY18 results

Sun Pharma top Sensex gainer; share price spikes 7% post Q4 FY18 results

Mon, May 28, 2018

Sun Pharma reported a rise of 6.96 per cent in its consolidated net profit for the quarter ended March 31, 2018 against Rs 1,223.71 crore reported for the corresponding quarter of previous fiscal year.

Sun Pharma Industries fourth-quarter profit up seven percent, beats estimates

Sun Pharma Industries fourth-quarter profit up seven percent, beats estimates

Fri, May 25, 2018

For the year ended March 31, the drug major posted a net profit of Rs 2,161.55 crore, down 68.96per cent from Rs 6,964.37 crore in 2016-17, Sun Pharma said in a regulatory filing.

Nifty kicks off March series on positive note, ends at 10,492, Sensex up 325 points

Nifty kicks off March series on positive note, ends at 10,492, Sensex up 325 points

Fri, Feb 23, 2018

The Nifty50 settled the March series on a positive note, settling just a tad below its crucial 10,500, tracking Asian markets after comments from US Federal Reserve official eased worries about faster rate hikes in the United States.

Nifty kicks off March series above 10,400; global cues positive

Nifty kicks off March series above 10,400; global cues positive

Fri, Feb 23, 2018

The benchmark indices kicked off the March series on a higher note with the Nifty50 reclaiming its crucial 10,400-mark, tracking positive trend seen in Asian markets. However, the broader momentum remained tepid.

Sensex jumps 200 points, Nifty reclaims 10,600 on positive global cues

Sensex jumps 200 points, Nifty reclaims 10,600 on positive global cues

Fri, Feb 16, 2018

The domestic market opened higher on Friday with the Nifty50 testing its crucial 10,600 mark, after Asian markets extended their recovery from two-month lows into a fifth day as the Wall Street market volatility gauge fell,

US drags down Sun Pharma's overall Q3FY18 earnings; consolidated PAT declines 75% yoy

US drags down Sun Pharma's overall Q3FY18 earnings; consolidated PAT declines 75% yoy

Wed, Feb 14, 2018

The company posted consolidated profit after tax (PAT) of Rs 365.39 crore - declining by 75.17% compared to Rs 1,471.82 crore in the corresponding period of the previous year.

Sensex, Nifty trade rangebound; Nifty PSU Bank top loser

Sensex, Nifty trade rangebound; Nifty PSU Bank top loser

Wed, Feb 14, 2018

The domestic market opened higher on Wednesday even as Asian markets were trading mixed as investor nerves were strained ahead of a US inflation report that could soothe, or inflame, fears of faster rate hikes globally.

Budget 2018: ITC, Sun Pharma among top trading calls ahead of Budget

Budget 2018: ITC, Sun Pharma among top trading calls ahead of Budget

Wed, Jan 31, 2018

Zee Business brings you four stocks that are not only smart Budget plays, but also hold strong fundamentals for a longer horizon.

Indices end in red after scaling new intra-day high

Indices end in red after scaling new intra-day high

Wed, Dec 27, 2017

Reliance Communications share continued its rally with closing 34.74% higher

Sun Pharma second-quarter profit dives 59%

Sun Pharma second-quarter profit dives 59%

Tue, Nov 14, 2017

Profit came in at 9.12 billion rupees ($139.48 million) in the quarter ended Sept. 30, compared with 22.35 billion rupees a year ago, the company said.

Sensex mirrors Asian markets gains, goes up after US Fed holds rates

Sensex mirrors Asian markets gains, goes up after US Fed holds rates

Thu, Nov 02, 2017

Sensex firm up 45.53 points, or 0.13%, to 33,645.80. It rallied 387.14 points to close at a record high of 33,600.27 in the previous session.

Sensex climbs over 110 points after Asian uptrend

Sensex climbs over 110 points after Asian uptrend

Thu, Aug 24, 2017

dian stocks today shrugged off weakness in US markets as the Sensex surged over 110 points, with domestic investors doing the job amid positive Asian cues.

Good news for Sun Pharma from US; IPO of Reliance Gen Insurance to come soon

Good news for Sun Pharma from US; IPO of Reliance Gen Insurance to come soon

Tue, Jun 13, 2017

This segment of Share Bazaar brings to you exclusive update about Sun Pharma. Suggestions from experts for today's trading and many important news updates are also featured in this segment. About Zee Business --------------------------

Sensex bounces back by 195 points, Nifty rises above 9,600-mark in early trade

Sensex bounces back by 195 points, Nifty rises above 9,600-mark in early trade

Fri, Jun 02, 2017

The key equity indices of Indian markets- Sensex and Nifty- have resumed their record-setting spree and have recovered to fresh lifetime highs in opening trade on Friday on sustained buying amid positive global cues.

Sun Pharma break down by 13% due to weak results and bad outlook

Sun Pharma break down by 13% due to weak results and bad outlook

Mon, May 29, 2017

Sun Pharma break down by 13% due to weak results and bad outlook. Watch this special segment and get to know more here.

Sun Pharma shares touch new lows as pricing pressure in US continues

Sun Pharma shares touch new lows as pricing pressure in US continues

Mon, May 29, 2017

Sun Pharma's fourth quarter results have been disappointing. The company said that pricing pressure in its US generic operation will continue for more time. Analysts, in the meantime, have begun downgrading the stock.

Sun Pharma says sales may fall in 2018 as US market gets tougher for generic drugs

Sat, May 27, 2017

Sun Pharmaceutical Industries MD Dilip Shanghvi has said on Friday that the US sales might fall in 2018 because of pressure on drug prices, signalling tough market conditions in the United States (US) for generic drugmakers.

Indian equities bullish on IMD forecast, indices scale record highs

Indian equities bullish on IMD forecast, indices scale record highs

Sat, May 13, 2017

The key Indian equity indices zoomed to new closing and 52-week highs, crossing their psychologically significant levels, riding on news reports which quoted a top India Meteorological Department (IMD) official predicting a higher rainfall than previously forecast as the El Nino weather condition had eased.

Sun Pharma shares rise as USFDA clears Mohali facility

Sun Pharma shares rise as USFDA clears Mohali facility

Tue, Mar 14, 2017

Sun Pharma said, “It's subsidiaries or associate was informed by the US FDA yesterday, that it will lift the import alert imposed on the Mohali (Punjab) manufacturing facility and remove the facility from the official action initiated (OAI) status."

Stocks of Sun Pharma, TCS, Infosys and Tech Mahindra are the Nifty Gainers

Stocks of Sun Pharma, TCS, Infosys and Tech Mahindra are the Nifty Gainers

Thu, Feb 16, 2017

Stocks of Sun Pharma, TCS, Infosys and Tech Mahindra are the Nifty Gainers. Watch this special segment and get to know more here.

Load More

LIVE TV

By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.

x